Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA
Pr. da Cruz Vermelha, 23 - Centro, Rio de Janeiro - RJ, 20230-130
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Adriana Melo
Flora de Moraes Lino da Silva
Open studies
Leukemia
PK, PD, Safety and Immunogenicity of Spectrila in Adults with Acute B-cell Lymphoblastic Leukaemia - MC-Spectrila.1/ALL - Syneos HealthSee more
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) - MK-1026-003 - Merck Sharp & Dohme Corp.See more
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) - waveLINE-006 - Merck Sharp & Dohme LLCSee more
PTCy and ATG for MSD and MUD Transplants - PTCy-ATG-001 - Instituto Nacional de Cancer, BrazilSee more
Breast Cancer
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) - lidERA - Hoffmann-La RocheSee more
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds - MorphineGEL - Instituto Nacional de Cancer, BrazilSee more
Cervical cancer
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer - Nivolumab - Hospital Israelita Albert EinsteinSee more
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer - AddChemo - Hospital do CoracaoSee more
Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer. - ACCESS-I - Instituto Nacional de Cancer, BrazilSee more
Lung cancer
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - ABBV-399 - AbbVieSee more
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004) - MK-1084-004 - Merck Sharp & Dohme LLCSee more
Non-Hodgkin Lymphoma
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) - waveLINE-006 - Merck Sharp & Dohme LLCSee more
PTCy and ATG for MSD and MUD Transplants - PTCy-ATG-001 - Instituto Nacional de Cancer, BrazilSee more
Colorectal cancer
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait - CCHOWW - Hospital Alemão Oswaldo CruzSee more
Gastrointestinal stromal tumors
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib - INSIGHT - Deciphera Pharmaceuticals LLCSee more
Graft versus Host Disease
PTCy and ATG for MSD and MUD Transplants - PTCy-ATG-001 - Instituto Nacional de Cancer, BrazilSee more
Head and neck cancer
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 - AHEAD-MERIT - BioNTech SESee more
Hpv
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer - AddChemo - Hospital do CoracaoSee more
Myelodysplastic Syndromes
PTCy and ATG for MSD and MUD Transplants - PTCy-ATG-001 - Instituto Nacional de Cancer, BrazilSee more
Rare diseases
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) - MK-1026-003 - Merck Sharp & Dohme Corp.See more
